Stay updated on AK104 Plus Anlotinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.

Latest updates to the AK104 Plus Anlotinib in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry v3.7.0 has been added to the study's history, while the older revision v3.6.6 has been removed. This indicates ongoing updates to the study record.SummaryDifference0.1%

- Check36 days agoChange DetectedA new site release label Revision: v3.6.6 was added to the history, and the previous label Revision: v3.6.5 was removed, reflecting an update to the release notes shown in the history view.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry, Revision: v3.6.5, is added to the study history. The previous entry, Revision: v3.6.4, is removed.SummaryDifference0.1%

- Check72 days agoChange DetectedNew revision entry 'Revision: v3.6.4' was added to the record history for the study page. The previous 'Revision: v3.6.3' entry was removed from the history.SummaryDifference0.1%

- Check93 days agoChange DetectedThe study record history shows a new revision entry for v3.6.3 and the previous v3.6.2 is removed. This reflects an update to the page's revision metadata.SummaryDifference0.1%

- Check100 days agoChange DetectedA new version entry v3.6.2 was added to the study record history, and the previous version v3.6.0 was removed, updating the version history for the study.SummaryDifference0.1%

Stay in the know with updates to AK104 Plus Anlotinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.